miércoles, 17 de septiembre de 2025

Roivant and Priovant say skin drug brepocitinib succeeded in trial The companies said they will file for approval with the FDA next year

https://www.statnews.com/2025/09/17/roivant-priovant-skin-drug-brepocitinib-fda/

No hay comentarios: